Home / Impressum

Search

WHO: "Virtually all countries must build up a monitoring system to control the spread of periodontitis and promote oral health." From: Strengthening the prevention of periodontal disease: The WHO approach

Prof. Dr. Thomas Hoffmann: "Periodontitis and peri-implantitis must […] become avoidable diseases. Early diagnostics and prophylaxis do play a decisive role here. In diagnostics, aMMP-8 could become a key technology in the process in the near future."

The WHO is focusing activities in the 21st century on oral health and the struggle against periodontitis. The weapon for this battle could be the aMMP-8 diagnostics.

Periodontitis significantly increases the risk for diabetes, cardio vascular illnesses, rheumatism and premature births. An early diagnosis can help to stop the process.

Dentognostics
+++ The enzyme aMMP-8 may provide an open gate for the bacteria to enter the bloodstream +++ The PerioMarker® rapid test reveals hidden inflammations +++ The aMMP-8 Rapid Test takes less than ten minutes +++ dentognostics offers high-efficiency products at the interface of medicine and dental medicine +++

Impressum – legal notice

dentognostics GmbH
Tatzendpromenade 2
D-07745 Jena

Tel. +49 (0) 3641-31058-0
Fax +49 (0) 3641-31058-99
email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Regional court of Jena HRB-Nr.: 209360
VAT number: DE212708330
Tax number.: 162/107/02729
Registry number: 07418641
Business manager: Dipl. Kfm. Kurt Maier

Responsible for content according to § 6 MDStV:
Dipl. Kfm. Kurt Maier

Scientific Advisor:
Dr.Lutz Netuschil
(private lecturer at Marburg University, department of periodontics)

All rights reserved unless explicitly indicated otherwise. When quoting from this homepage, please give a source reference. The content here is only designed to communicate a general and non-binding overview of dentognostics GmbH and its partners. dentognostics GmbH  cannot be held liable for the completeness or accuracy of the content. Changes or amendments are made without prior warning.

Liability: In spite of careful control of content, we cannot be held liable for the content of external links. The provider is exclusively responsible for the content on linked websites.
 

The PerioMarker®

rapid test reveals hidden inflammations. It can identify the risk even before any clinical signs become visible, such as irreversible destruction of periodontal tissue and jawbones or loosening of teeth.

read more

aMMP8 degrades tissue

An aMMP-8 rapid test is especially effective in indicating previously concealed periodontal inflammations in at-risk groups. And early detection means that preventive measures can be taken before symptoms set in.

read more

Few patients know,

that an inflammation in the mouth can increase significantly the risk of such serious diseases as heart attack, apoplectic stroke and diabetes.

read more

For physicians:
ORI Oral RiskIndicator aMMP-8 Rapid Test Professional